STOCK TITAN

Mindset Pharma Inc. - $MSSTF STOCK NEWS

Welcome to our dedicated page for Mindset Pharma news (Ticker: $MSSTF), a resource for investors and traders seeking the latest updates and insights on Mindset Pharma stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Mindset Pharma's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Mindset Pharma's position in the market.

Rhea-AI Summary
Mindset Pharma Inc. has been acquired by Otsuka Pharmaceutical Co., Ltd. in an arrangement agreement. Shareholders will receive CA$0.75 in cash for each Common Share. The Common Shares will be delisted from the Canadian Securities Exchange.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Mindset Pharma Inc. has obtained the final order from the Supreme Court of British Columbia approving the plan of arrangement under the Business Corporations Act. The company will be acquired by a subsidiary of Otsuka America, Inc. Closing of the arrangement is expected on October 26, 2023, and the company's shares will be delisted from CSE, OTCQB, and FSE.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Mindset Pharma announces overwhelming approval of special resolution for acquisition
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.44%
Tags
none
Rhea-AI Summary
Mindset Pharma Inc. clarifies disclosure in management information circular for special meeting of shareholders.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.17%
Tags
none
-
Rhea-AI Summary
Mindset Pharma Inc. announces mailing of management information circular for special meeting to approve a statutory plan of arrangement involving Mindset, Otsuka America, Inc., and 1435816 B.C. Ltd.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Mindset Pharma Inc. announces definitive agreement for acquisition by Otsuka Pharmaceutical Co., Ltd.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
16.39%
Tags
Rhea-AI Summary
Mindset Pharma Inc. has received approval to initiate a Phase II study of its novel psilocin prodrug, MSP-1014, for the treatment of major depressive disorder. The study will evaluate the safety and efficacy of the medication.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.98%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.86%
Tags
conferences
Mindset Pharma Inc.

OTC:MSSTF

MSSTF Rankings

MSSTF Stock Data

54.51M
74.78M
9.58%
0.07%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
Canada
Toronto